サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：ベッカー母斑の世界市場：産業分析、規模、シェア、成長、動向、予測（2024年～2032年）
市場調査レポート
商品コード
1408992

ベッカー母斑の世界市場：産業分析、規模、シェア、成長、動向、予測（2024年～2032年）

Global Becker's Nevus Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032
出版日: | 発行: Value Market Research | ページ情報: 英文 336 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.70円
ベッカー母斑の世界市場：産業分析、規模、シェア、成長、動向、予測（2024年～2032年）
出版日: 2024年01月01日
発行: Value Market Research
ページ情報: 英文 336 Pages
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

ベッカー母斑市場の世界需要は、調査期間2023年～2030年のCAGR7.56%で、2022年の9億2,160万米ドルから2030年には16億5,101万米ドル近くの市場規模に達すると推定されます。

ベッカー母斑は、ベッカー黒色症としても知られ、皮膚に茶色がかった大きな斑点ができるまれな皮膚疾患です。この疾患は通常思春期に現れ、男性に多いです。母斑またはほくろのような病変は、しばしば肩、胸、または背中の上部に発現します。

市場力学

この分野の研究開発と医療開発に影響を与える要因としては、皮膚科学的理解の進歩、美容的側面に対する患者の関心、皮膚科学技術の進歩などが挙げられます。皮膚病態の知識が発展するにつれて、ベッカー母斑の新たな診断法や治療法の探求に対する関心も高まっているものと思われます。特に美容的あるいは症状的な問題に対する解決策を求める患者の要求は、より効果的で患者に優しいアプローチの研究を推進することができます。さらに、医療専門分野間の学際的な協力は、ベッカー母斑をより包括的に理解し、全人的な治療戦略を開発することに貢献する可能性があります。医療分野では、従来の市場主導の視点よりも、知識の向上、診断法の改善、安全で効率的な治療法の開拓に重点が置かれています。

調査レポートは、ポーターのファイブフォースモデル、市場魅力度分析、バリューチェーン分析を取り上げています。これらのツールは、業界の構造を明確に把握し、競合の魅力を世界レベルで評価するのに役立ちます。さらに、これらのツールはベッカー母斑の世界市場における各セグメントを包括的に評価することもできます。べッカー母斑産業の成長と動向は、この調査に全体的なアプローチを提供します。

地域分析

本セクションでは、北米、欧州、アジア太平洋、ラテンアメリカ、中東・アフリカにおけるベッカー母斑市場の現在および将来の需要を強調する地域展望をカバーします。さらに、著名な全地域における個々の用途セグメントの需要・推定・予測にも焦点を当てています。

カスタム要件がある場合は、お問い合わせください。当社の調査チームは、お客様のニーズに応じてカスタマイズしたレポートを提供することができます。

目次

第1章 序文

第2章 エグゼクティブサマリー

  • 市場のハイライト
  • 世界市場スナップショット

第3章 ベッカー母斑：産業分析

  • イントロダクション：市場力学
  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 業界動向
  • ポーターのファイブフォース分析
  • 市場魅力度分析

第4章 バリューチェーン分析

  • バリューチェーン分析
  • 原材料分析
    • 原材料リスト
    • 原材料メーカーリスト
    • 主要原材料の価格動向
  • 潜在的バイヤーのリスト
  • マーケティングチャネル
    • ダイレクトマーケティング
    • インダイレクトマーケティング
    • マーケティングチャネル発展動向

第5章 ベッカー母斑の世界市場分析：タイプ別

  • タイプ別の概要
  • 実績データと予測データ
  • タイプ別の分析
  • 肩
  • 体幹
  • その他

第6章 ベッカー母斑の世界市場分析：疾患発生別

  • 疾患発生別の概要
  • 実績データと予測データ
  • 疾患発生別の分析
  • 生下時
  • 出生後

第7章 ベッカー母斑の世界市場分析：治療法別

  • 治療法別の概要
  • 実績データと予測データ
  • 治療法別の分析
  • 薬物療法
  • レーザー治療
  • その他

第8章 ベッカー母斑の世界市場分析：エンドユーザー別

  • エンドユーザー別の概要
  • 実績データと予測データ
  • エンドユーザー別の分析
  • 病院
  • 専門クリニック
  • その他

第9章 ベッカー母斑の世界市場分析：流通チャネル別

  • 流通チャネル別の概要
  • 実績データと予測データ
  • 流通チャネル別の分析
  • 病院薬局
  • 小売薬局
  • オンライン薬局
  • その他

第10章 ベッカー母斑の世界市場分析：地域別

  • 地域別の展望
  • イントロダクション
  • 北米の売上分析
    • 概要・実績・予測
    • 北米：セグメント別
    • 北米：国別
    • 米国
    • カナダ
    • メキシコ
  • 欧州の売上分析
    • 概要・実績・予測
    • 欧州：セグメント別
    • 欧州：国別
    • 英国
    • フランス
    • ドイツ
    • イタリア
    • ロシア
    • その他欧州
  • アジア太平洋地域の売上分析
    • 概要・実績・予測
    • アジア太平洋地域：セグメント別
    • アジア太平洋地域：国別
    • 中国
    • インド
    • 日本
    • 韓国
    • オーストラリア
    • 東南アジア
    • その他アジア太平洋地域
  • ラテンアメリカの売上分析
    • 概要・実績・予測
    • ラテンアメリカ：セグメント別
    • ラテンアメリカ：国別
    • ブラジル
    • アルゼンチン
    • ペルー
    • チリ
    • その他ラテンアメリカ
  • 中東とアフリカの売上分析
    • 概要・実績・予測
    • 中東・アフリカ：セグメント別
    • 中東・アフリカ：国別
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • 南アフリカ
    • その他中東とアフリカ

第11章 ベッカー母斑企業の競合情勢

  • 市場競合
  • 提携／協力／合意
  • 合併・買収
  • 新製品発売
  • その他の開発

第12章 企業プロファイル

  • 企業シェア分析
  • 市場集中度
  • Boehringer Ingelheim
  • Eisai Inc.
  • Pfizer Inc.
  • Sanofi S.A.
  • Teva Pharmaceutical Industries Ltd.
  • Bayer Healthcare AG
  • Aspen Holdings
  • Mitsubishi Tanabe Pharma Corporation
  • Abbott India Limited
  • GlaxoSmithKline Plc.
  • Bristol-Myers Squibb Company
  • Mitsubishi Tanabe Pharma Corporation
図表

LIST OF TABLES

  • Market Snapshot
  • Drivers : Impact Analysis
  • Restraints : Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • Analysis by Type (USD MN)
  • Shoulder Market Sales by Geography (USD MN)
  • Trunk Market Sales by Geography (USD MN)
  • Others Market Sales by Geography (USD MN)
  • Analysis Market by Disease Occurrence (USD MN)
  • Birth Market Sales by Geography (USD MN)
  • After Birth Market Sales by Geography (USD MN)
  • Analysis by Treatment (USD MN)
  • Medication Market Sales by Geography (USD MN)
  • Laser Treatment Market Sales by Geography (USD MN)
  • Others Market Sales by Geography (USD MN)
  • Analysis by End User (USD MN)
  • Hospitals Market Sales by Geography (USD MN)
  • Specialty Clinics Market Sales by Geography (USD MN)
  • Others Market Sales by Geography (USD MN)
  • Analysis by Distribution Channel (USD MN)
  • Hospital Pharmacies Market Sales by Geography (USD MN)
  • Retail Pharmacies Market Sales by Geography (USD MN)
  • Online Pharmacies Market Sales by Geography (USD MN)
  • Others Market Sales by Geography (USD MN)
  • Global Becker'S Nevus Market Sales by Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United State Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate by Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • South East Asia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Becker'S Nevus Report
  • Market Research Process
  • Market Research Methodology
  • Global Becker'S Nevus Market Size, by Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis by Type
  • Market Attractiveness Analysis by Disease Occurrence
  • Market Attractiveness Analysis by Treatment
  • Market Attractiveness Analysis by End User
  • Market Attractiveness Analysis by Distribution Channel
  • Market Attractiveness Analysis by Region
  • Value Chain Analysis
  • Global Market Analysis by Type (USD MN)
  • Shoulder Market Sales by Geography (USD MN)
  • Trunk Market Sales by Geography (USD MN)
  • Others Market Sales by Geography (USD MN)
  • Global Market Analysis by Disease Occurrence (USD MN)
  • Birth Market Sales by Geography (USD MN)
  • After Birth Market Sales by Geography (USD MN)
  • Global Market Analysis by Treatment (USD MN)
  • Medication Market Sales by Geography (USD MN)
  • Laser Treatment Market Sales by Geography (USD MN)
  • Others Market Sales by Geography (USD MN)
  • Global Market Analysis by End User (USD MN)
  • Hospitals Market Sales by Geography (USD MN)
  • Specialty Clinics Market Sales by Geography (USD MN)
  • Others Market Sales by Geography (USD MN)
  • Global Market Analysis by Distribution Channel (USD MN)
  • Hospital Pharmacies Market Sales by Geography (USD MN)
  • Retail Pharmacies Market Sales by Geography (USD MN)
  • Online Pharmacies Market Sales by Geography (USD MN)
  • Others Market Sales by Geography (USD MN)
  • Global Market Sales (USD MN)
  • North America Market Sales (USD MN)
  • Europe Market Sales (USD MN)
  • Asia Pacific Market Sales (USD MN)
  • Latin America Market Sales (USD MN)
  • Middle East & Africa Market Sales (USD MN)
  • Recent Development in Industry
  • Top Company Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.

目次
Product Code: VMR112113256

The global demand for Becker's Nevus Market is presumed to reach the market size of nearly USD 1651.01 MN by 2030 from USD 921.6 MN in 2022 with a CAGR of 7.56% under the study period 2023 - 2030.

Becker's nevus, also known as Becker's melanosis, is a rare skin disorder in which a large, brownish patch develops on the skin. This condition typically appears during adolescence and is more common in males. The nevus, or mole-like lesion, often presents on the shoulders, chest, or upper back.

MARKET DYNAMICS

The factors influencing research and medical developments in this area include advancements in dermatological understanding, patient concerns about cosmetic aspects and technological progress in dermatology. As the knowledge of dermatological conditions evolves, there is likely increased interest in exploring new diagnostic methods and treatment options for Becker's nevus. Patient demand for solutions, particularly addressing cosmetic or symptomatic issues, can drive research into more effective and patient-friendly approaches. Additionally, interdisciplinary collaboration among medical specialties may contribute to a more comprehensive understanding of Becker's nevus and the development of holistic treatment strategies. The focus in the medical field remains on advancing knowledge, improving diagnostics, and developing safe and efficient treatments rather than a conventional market-driven perspective.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of becker's nevus. The growth and trends of becker's nevus industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the becker's nevus market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Type

  • Shoulder
  • Trunk
  • Others

By Disease Occurrence

  • Birth
  • After Birth

By Treatment

  • Medication
  • Laser Treatment
  • Others

By End User

  • Hospitals
  • Specialty Clinics
  • Others

By Distribution Channel

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Others

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Becker's Nevus market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Becker's Nevus market include Boehringer Ingelheim, Eisai Inc., Pfizer Inc., Sanofi S.A., Teva Pharmaceutical Industries Ltd., Bayer Healthcare AG, Aspen Holdings, Mitsubishi Tanabe Pharma Corporation, Abbott India Limited, GlaxoSmithKline Plc., Bristol-Myers Squibb Company and Mitsubishi Tanabe Pharma Corporation among others. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1 . PREFACE

  • 1.1. Report Description
    • 1.1.1. Objective
    • 1.1.2. Target Audience
    • 1.1.3. Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1. Market Research Process
    • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3 . BECKER'S NEVUS - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Type
    • 3.7.2 Market Attractiveness Analysis By Disease Occurrence
    • 3.7.3 Market Attractiveness Analysis By Treatment
    • 3.7.4 Market Attractiveness Analysis By End User
    • 3.7.5 Market Attractiveness Analysis By Distribution Channel
    • 3.7.6 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1. List of Raw Materials
    • 4.2.2. Raw Material Manufactures List
    • 4.2.3. Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1. Direct Marketing
    • 4.4.2. Indirect Marketing
    • 4.4.3. Marketing Channel Development Trend

5 . GLOBAL BECKER'S NEVUS MARKET ANALYSIS BY TYPE

  • 5.1 Overview by Type
  • 5.2 Historical and Forecast Data
  • 5.3 Analysis by Type
  • 5.4 Shoulder Historic and Forecast Sales by Regions
  • 5.5 Trunk Historic and Forecast Sales by Regions
  • 5.6 Others Historic and Forecast Sales by Regions

6 . GLOBAL BECKER'S NEVUS MARKET ANALYSIS BY DISEASE OCCURRENCE

  • 6.1 Overview by Disease Occurrence
  • 6.2 Historical and Forecast Data
  • 6.3 Analysis by Disease Occurrence
  • 6.4 Birth Historic and Forecast Sales by Regions
  • 6.5 After Birth Historic and Forecast Sales by Regions

7 . GLOBAL BECKER'S NEVUS MARKET ANALYSIS BY TREATMENT

  • 7.1 Overview by Treatment
  • 7.2 Historical and Forecast Data
  • 7.3 Analysis by Treatment
  • 7.4 Medication Historic and Forecast Sales by Regions
  • 7.5 Laser Treatment Historic and Forecast Sales by Regions
  • 7.6 Others Historic and Forecast Sales by Regions

8 . GLOBAL BECKER'S NEVUS MARKET ANALYSIS BY END USER

  • 8.1 Overview by End User
  • 8.2 Historical and Forecast Data
  • 8.3 Analysis by End User
  • 8.4 Hospitals Historic and Forecast Sales by Regions
  • 8.5 Specialty Clinics Historic and Forecast Sales by Regions
  • 8.6 Others Historic and Forecast Sales by Regions

9 . GLOBAL BECKER'S NEVUS MARKET ANALYSIS BY DISTRIBUTION CHANNEL

  • 9.1 Overview by Distribution Channel
  • 9.2 Historical and Forecast Data
  • 9.3 Analysis by Distribution Channel
  • 9.4 Hospital Pharmacies Historic and Forecast Sales by Regions
  • 9.5 Retail Pharmacies Historic and Forecast Sales by Regions
  • 9.6 Online Pharmacies Historic and Forecast Sales by Regions
  • 9.7 Others Historic and Forecast Sales by Regions

10 . GLOBAL BECKER'S NEVUS MARKET ANALYSIS BY GEOGRAPHY

  • 10.1. Regional Outlook
  • 10.2. Introduction
  • 10.3. North America Sales Analysis
    • 10.3.1. Overview, Historic and Forecast Data Sales Analysis
    • 10.3.2. North America By Segment Sales Analysis
    • 10.3.3. North America By Country Sales Analysis
    • 10.3.4. United State Sales Analysis
    • 10.3.5. Canada Sales Analysis
    • 10.3.6. Mexico Sales Analysis
  • 10.4. Europe Sales Analysis
    • 10.4.1. Overview, Historic and Forecast Data Sales Analysis
    • 10.4.2. Europe by Segment Sales Analysis
    • 10.4.3. Europe by Country Sales Analysis
    • 10.4.4. United Kingdom Sales Analysis
    • 10.4.5. France Sales Analysis
    • 10.4.6. Germany Sales Analysis
    • 10.4.7. Italy Sales Analysis
    • 10.4.8. Russia Sales Analysis
    • 10.4.9. Rest Of Europe Sales Analysis
  • 10.5. Asia Pacific Sales Analysis
    • 10.5.1. Overview, Historic and Forecast Data Sales Analysis
    • 10.5.2. Asia Pacific by Segment Sales Analysis
    • 10.5.3. Asia Pacific by Country Sales Analysis
    • 10.5.4. China Sales Analysis
    • 10.5.5. India Sales Analysis
    • 10.5.6. Japan Sales Analysis
    • 10.5.7. South Korea Sales Analysis
    • 10.5.8. Australia Sales Analysis
    • 10.5.9. South East Asia Sales Analysis
    • 10.5.10. Rest Of Asia Pacific Sales Analysis
  • 10.6. Latin America Sales Analysis
    • 10.6.1. Overview, Historic and Forecast Data Sales Analysis
    • 10.6.2. Latin America by Segment Sales Analysis
    • 10.6.3. Latin America by Country Sales Analysis
    • 10.6.4. Brazil Sales Analysis
    • 10.6.5. Argentina Sales Analysis
    • 10.6.6. Peru Sales Analysis
    • 10.6.7. Chile Sales Analysis
    • 10.6.8. Rest of Latin America Sales Analysis
  • 10.7. Middle East & Africa Sales Analysis
    • 10.7.1. Overview, Historic and Forecast Data Sales Analysis
    • 10.7.2. Middle East & Africa by Segment Sales Analysis
    • 10.7.3. Middle East & Africa by Country Sales Analysis
    • 10.7.4. Saudi Arabia Sales Analysis
    • 10.7.5. UAE Sales Analysis
    • 10.7.6. Israel Sales Analysis
    • 10.7.7. South Africa Sales Analysis
    • 10.7.8. Rest Of Middle East And Africa Sales Analysis

11 . COMPETITIVE LANDSCAPE OF THE BECKER'S NEVUS COMPANIES

  • 11.1. Becker'S Nevus Market Competition
  • 11.2. Partnership/Collaboration/Agreement
  • 11.3. Merger And Acquisitions
  • 11.4. New Product Launch
  • 11.5. Other Developments

12 . COMPANY PROFILES OF BECKER'S NEVUS INDUSTRY

  • 12.1. Company Share Analysis
  • 12.2. Market Concentration Rate
  • 12.3. Boehringer Ingelheim
    • 12.3.1. Company Overview
    • 12.3.2. Company Revenue
    • 12.3.3. Products
    • 12.3.4. Recent Developments
  • 12.4. Eisai Inc.
    • 12.4.1. Company Overview
    • 12.4.2. Company Revenue
    • 12.4.3. Products
    • 12.4.4. Recent Developments
  • 12.5. Pfizer Inc.
    • 12.5.1. Company Overview
    • 12.5.2. Company Revenue
    • 12.5.3. Products
    • 12.5.4. Recent Developments
  • 12.6. Sanofi S.A.
    • 12.6.1. Company Overview
    • 12.6.2. Company Revenue
    • 12.6.3. Products
    • 12.6.4. Recent Developments
  • 12.7. Teva Pharmaceutical Industries Ltd.
    • 12.7.1. Company Overview
    • 12.7.2. Company Revenue
    • 12.7.3. Products
    • 12.7.4. Recent Developments
  • 12.8. Bayer Healthcare AG
    • 12.8.1. Company Overview
    • 12.8.2. Company Revenue
    • 12.8.3. Products
    • 12.8.4. Recent Developments
  • 12.9. Aspen Holdings
    • 12.9.1. Company Overview
    • 12.9.2. Company Revenue
    • 12.9.3. Products
    • 12.9.4. Recent Developments
  • 12.10. Mitsubishi Tanabe Pharma Corporation
    • 12.10.1. Company Overview
    • 12.10.2. Company Revenue
    • 12.10.3. Products
    • 12.10.4. Recent Developments
  • 12.11. Abbott India Limited
    • 12.11.1. Company Overview
    • 12.11.2. Company Revenue
    • 12.11.3. Products
    • 12.11.4. Recent Developments
  • 12.12. GlaxoSmithKline Plc.
    • 12.12.1. Company Overview
    • 12.12.2. Company Revenue
    • 12.12.3. Products
    • 12.12.4. Recent Developments
  • 12.13. Bristol-Myers Squibb Company
    • 12.13.1. Company Overview
    • 12.13.2. Company Revenue
    • 12.13.3. Products
    • 12.13.4. Recent Developments
  • 12.14. Mitsubishi Tanabe Pharma Corporation
    • 12.14.1. Company Overview
    • 12.14.2. Company Revenue
    • 12.14.3. Products
    • 12.14.4. Recent Developments
  • 12.15. Others
    • 12.15.1. Company Overview
    • 12.15.2. Company Revenue
    • 12.15.3. Products
    • 12.15.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies